NEW YORK (GenomeWeb) – Software firm Syapse said today that it raised $10 million in a Series B financing round led by Safeguard Scientifics with participation from Series A investor The Social+Capital Partnership.

Syapse said that it will use the funds to expand its sales, marketing, and client services, as well as further accelerate product development. The funds will also support the firm's efforts to provide its Precision Medicine Data platform to healthcare providers, enabling them to use genomics and clinical data in their treatment decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.